Mirum Pharmaceuticals, Inc. (MIRM) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - MIRM

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth54.74%

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-3.93%

5Y CAGR33.50%

10Y CAGRN/A

Equity

1Y Growth39.47%

5Y CAGRN/A

10Y CAGRN/A

Cash Flow

1Y Growth440.70%

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	54.7%	67.2%	89.1%	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	80.8%	109.1%	160.1%	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	141.8%	212.1%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	302.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - MIRM

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Mirum Pharmaceuticals, Inc.

Compare with peers

Explore

Growth Analysis - MIRM

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Mirum Pharmaceuticals, Inc.

Compare with peers

Explore